Antiretroviral Treatment and HIV-Associated Anemia in Tanzania
Author Information
Author(s): Johannessen Asgeir, Naman Ezra, Gundersen Svein G, Bruun Johan N
Primary Institution: Oslo University Hospital
Hypothesis
What is the effect of antiretroviral treatment on HIV-associated anemia in rural Tanzania?
Conclusion
Antiretroviral treatment significantly increases hemoglobin levels in anemic patients, but many still remain anemic after 12 months.
Supporting Evidence
- 77.4% of patients were anemic at enrollment.
- Mean hemoglobin increased from 9.9 g/dL to 12.4 g/dL after 12 months of ART.
- 39.1% of anemic patients had microcytosis and hypochromia.
Takeaway
This study shows that medicine for HIV can help people with low blood levels, but some still need more help even after a year.
Methodology
The study included HIV-infected adults who were anemic at ART initiation and had follow-up hemoglobin measurements after 12 months.
Potential Biases
Potential bias due to observational nature and lack of randomization.
Limitations
Selection bias may have occurred as only patients with follow-up hemoglobin measurements were included.
Participant Demographics
Mean age was 36 years, with 73.5% being women.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI 1.22-15.5 for MCV, 95% CI 1.03-8.19 for zidovudine regimen
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website